PTHrP-linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone source and Clinical and Metabolic Correlates

A patient diagnosed with metastatic melanoma developed the paraneoplastic syndrome of humoral hypercalcemia of malignancy and cachexia after receiving ipilumumab. The cause of the hypercalcemia was thought to be secondary to parathyroid hormone related peptide (PTHrP) as plasma levels were found to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Semin Oncol
Asıl Yazarlar: Mills, Theresa Anne, Orloff, Marlana, Domingo-Vidal, Marina, Cotzia, Paolo, Birbe, Ruth, Draganova-Tacheva, Rossitza, Martinez-Cantarin, Maria Paula, Tuluc, Madalina, Martinez-Outschoorn, Ubaldo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663680/
https://ncbi.nlm.nih.gov/pubmed/26615135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2015.09.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller